William E. Rote - Jan 23, 2024 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
SENIOR VICE PRESIDENT, R&D
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jan 23, 2024
Transactions value $
-$18,476
Form type
4
Date filed
1/25/2024, 04:10 PM
Previous filing
Sep 5, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$18.5K -2.06K -3.3% $8.96 60.5K Jan 23, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
F2 Includes 1,373 shares of the Issuer's common stock acquired by the reporting person on November 30, 2023 pursuant to an employee stock purchase program.